-Innovative modular PureApta service platform for selection of modified aptamers with diagnostic and therapeutic potential (NCBR/Szybka Ścieżka POIR.01.01.01-00-0474/16)

-Service technology platform for discovery of antibody fragments with therapeutic and diagnostic potential (NCBR, action 1.1.1, project number: POIR.01.01.01-00-0749/16)

-The development and implementation of a bacteriophage preparation intended to use in the treatment and prevention of the American and European foulbrood of honey bee (NCBR, action 4.1.4, project number: POIR.04.01.04-00-0126/16). Partners: Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, Wroclaw University of Environmental and Life Sciences, Bioscientia Ltd.




-Development of a field diagnostic test for infection of honey bee pathogen Nosema ceranae (NCBR/PBS)

-Development of vaccines for cattle and pigs based on recombinant antigens from Histophilus somni (NCBR/PBS)

-Optimization of therapeutic proteins production in hen oviduct (NCBR/PBS)

-Development of Rapid Multi-Test for diagnosis of viral infections contributing to colony collapse disorder of honeybees (EUREKA E!/Eurostars)

 

-Antibody-based diagnostics development using lung cancer specific microRNAs as biomarkers ("Mozart" partnership of science and business)

-Development of human induced pluripotent stem cells (iPS) production for medical use ("Mozart" partnership of science and business)